Angiosarcoma Treatment Market Trends

  • Report ID: 5327
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Angiosarcoma Treatment Market Trends

Growth Drivers

  • Increasing Research and Development for Angiosarcoma Treatment - Due to numerous recent studies and advancements, the angiosarcoma treatment market has seen substantial expansion. Clinical and radiological data, along with medical history, are typically used to make the diagnosis of angiosarcoma. Additionally, the introduction of new therapies for angiosarcoma aids in quickening market expansion. For example, a November 2022 article titled Cutaneous angiosarcoma treated with taxane-based radiation therapy mentions the significance of taxane-derived agents like paclitaxel and docetaxel as primary chemotherapy for the treatment of cutaneous angiosarcoma. In addition, radiation therapy with taxanes significantly improved overall survival relative to surgery or radiotherapy and had a high response rate.
  • Rising Technological Advancement for Angiosarcoma Treatment - The inner membrane of blood arteries and lymph vessels is where angiosarcoma occurs, and significant developments from top firms are fostering angiosarcoma treatment market expansion. With cutaneous angiosarcoma accounting for about 57.21% of cases, the skin is the area most commonly afflicted. These successful developments contribute to the development of novel therapeutic approaches and the enhancement of care for the vast majority of angiosarcoma patients. For instance, a Springer Journal paper from April 2023 claims that topological immunological pathways of Asian head and neck angiosarcoma are revealed by spatial transcriptomics. It entails revealing the geometric tumor immunological landscape of angiosarcoma using spatial transcriptome profiling utilizing the 10x Genomics Visium platform on typical cases distinguished by the existence or absence of UV signals and HHV-7.

Challenges

  • Complexities Associated with Lymphangiosarcoma - Complications of lymphoma include cellulitis, musculoskeletal pain, psychological distress, and increased risk of malignancy. Cellulitis often occurs with oral antibiotics, and cellulitis is a bacterial infection of the dermis and subcutaneous tissue under the skin and is the most common complication associated with lymphoma. Thus, due to the above factors, the market is expected to slow down during the forecast period.
  • High Cost of Treatment is Assumed to Hamper the Market Expansion in the Upcoming Time Period.
  • Lack of Effective Treatments is Set to Restrict the Market Growth in the Forecast Timeframe.  

Angiosarcoma Treatment Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.5%

Base Year Market Size (2024)

USD 279.68 million

Forecast Year Market Size (2037)

USD 560.97 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5327
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of angiosarcoma treatment is assessed at USD 292.76 million.

The angiosarcoma treatment market size was valued at USD 279.68 million in 2024 and is expected to reach USD 560.97 million by 2037, expanding at around 5.5% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of cancer and growing technological advancement will boost the market growth.

North America industry is poised to dominate majority revenue share of 35% by 2037, driven by development of new medical infrastructure in the region.

The major players in the market are Bayer AG, GlaxoSmithKline plc., Sanofi S.A., Amgen Inc., Merck & Co. Inc., AbbiVie Inc., Eli Lilly and Company, Bausch Health, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample